{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:52:40Z","timestamp":1789588360067,"version":"build-2803163510"},"reference-count":182,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100015391","name":"Sveu\u010dili\u0161te u Splitu","doi-asserted-by":"publisher","award":["IP-UNIST-32"],"award-info":[{"award-number":["IP-UNIST-32"]}],"id":[{"id":"10.13039\/501100015391","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00109-026-02693-7","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T02:18:27Z","timestamp":1781576307000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Molecular determinants of thromboinflammatory activation in inflammatory bowel disease"],"prefix":"10.1007","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3112-0656","authenticated-orcid":false,"given":"Roko","family":"\u0160anti\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3452-389X","authenticated-orcid":false,"given":"Nikola","family":"Pavlovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9696-3359","authenticated-orcid":false,"given":"Marko","family":"Kumri\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5433-5063","authenticated-orcid":false,"given":"Marino","family":"Vilovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1634-0635","authenticated-orcid":false,"given":"Jo\u0161ko","family":"Bo\u017ei\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"2693_CR1","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1157\/13078423","volume":"125","author":"J Luis Mendoza","year":"2005","unstructured":"Luis Mendoza J, Lana R, Taxonera C, Alba C, Izquierdo S, D\u00edaz-Rubio M (2005) Manifestaciones extraintestinales en la enfermedad inflamatoria intestinal: diferencias entre la enfermedad de Crohn y la colitis ulcerosa. Med Clin 125:297\u2013300. https:\/\/doi.org\/10.1157\/13078423","journal-title":"Med Clin"},{"key":"2693_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.32074\/1591-951X-235","volume":"113","author":"V Villanacci","year":"2021","unstructured":"Villanacci V, Reggiani-Bonetti L, Salviato T, Leoncini G, Cadei M, Albarello L et al (2021) Histopathology of IBD colitis. A practical approach from the pathologists of the Italian Group for the study of the gastrointestinal tract (GIPAD). Pathologica 113:39\u201353. https:\/\/doi.org\/10.32074\/1591-951X-235","journal-title":"Pathologica"},{"key":"2693_CR3","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i1.91","volume":"20","author":"Y-Z Zhang","year":"2014","unstructured":"Zhang Y-Z (2014) Inflammatory bowel disease: pathogenesis. World J Gastroenterol 20:91. https:\/\/doi.org\/10.3748\/wjg.v20.i1.91","journal-title":"World J Gastroenterol"},{"key":"2693_CR4","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.3390\/ijms24021526","volume":"24","author":"A Saez","year":"2023","unstructured":"Saez A, Herrero-Fernandez B, Gomez-Bris R, S\u00e1nchez-Martinez H, Gonzalez-Granado JM (2023) Pathophysiology of inflammatory bowel disease: innate immune system. Int J Mol Sci 24:1526. https:\/\/doi.org\/10.3390\/ijms24021526","journal-title":"Int J Mol Sci"},{"key":"2693_CR5","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s43556-024-00207-w","volume":"5","author":"Y Liang","year":"2024","unstructured":"Liang Y, Li Y, Lee C, Yu Z, Chen C, Liang C (2024) Ulcerative colitis: molecular insights and intervention therapy. Mol Biomed 5:42. https:\/\/doi.org\/10.1186\/s43556-024-00207-w","journal-title":"Mol Biomed"},{"key":"2693_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/387891","volume":"2015","author":"T Sheth","year":"2015","unstructured":"Sheth T, Pitchumoni CS, Das KM (2015) Management of musculoskeletal manifestations in inflammatory bowel disease. Gastroenterol Res Pract 2015:1\u201311. https:\/\/doi.org\/10.1155\/2015\/387891","journal-title":"Gastroenterol Res Pract"},{"key":"2693_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1234535","volume":"14","author":"R He","year":"2023","unstructured":"He R, Zhao S, Cui M, Chen Y, Ma J, Li J et al (2023) Cutaneous manifestations of inflammatory bowel disease: basic characteristics, therapy, and potential pathophysiological associations. Front Immunol 14:1234535. https:\/\/doi.org\/10.3389\/fimmu.2023.1234535","journal-title":"Front Immunol"},{"key":"2693_CR8","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1053\/j.gastro.2021.07.042","volume":"161","author":"G Rogler","year":"2021","unstructured":"Rogler G, Singh A, Kavanaugh A, Rubin DT (2021) Extraintestinal manifestations of inflammatory bowel disease: current concepts, treatment, and implications for disease management. Gastroenterology 161:1118\u201332. https:\/\/doi.org\/10.1053\/j.gastro.2021.07.042","journal-title":"Gastroenterology"},{"key":"2693_CR9","doi-asserted-by":"publisher","first-page":"6142","DOI":"10.3748\/wjg.v27.i36.6142","volume":"27","author":"D Alicic","year":"2021","unstructured":"Alicic D, Martinovic D, Rusic D, Zivkovic PM, Tadin Hadjina I, Vilovic M et al (2021) Urotensin II levels in patients with inflammatory bowel disease. World J Gastroenterol 27:6142\u201353. https:\/\/doi.org\/10.3748\/wjg.v27.i36.6142","journal-title":"World J Gastroenterol"},{"key":"2693_CR10","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.3748\/wjg.v30.i13.1899","volume":"30","author":"A Tonkic","year":"2024","unstructured":"Tonkic A, Kumric M, Akrapovic Olic I, Rusic D, Zivkovic PM, Supe Domic D et al (2024) Growth differentiation factor-15 serum concentrations reflect disease severity and anemia in patients with inflammatory bowel disease. World J Gastroenterol 30:1899\u2013910. https:\/\/doi.org\/10.3748\/wjg.v30.i13.1899","journal-title":"World J Gastroenterol"},{"key":"2693_CR11","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1136\/gut.2003.025411","volume":"53","author":"W Miehsler","year":"2004","unstructured":"Miehsler W, Reinisch W, Valic E, Osterode W, Tillinger W, Feichtenschlager T et al (2004) Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut 53:542\u20138. https:\/\/doi.org\/10.1136\/gut.2003.025411","journal-title":"Gut"},{"key":"2693_CR12","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.14309\/ajg.0000000000001237","volume":"116","author":"CN Bernstein","year":"2021","unstructured":"Bernstein CN, Nugent Z, Singh H (2021) Persistently high rate of venous thromboembolic disease in inflammatory bowel disease: a population-based study. Am J Gastroenterol 116:1476\u201384. https:\/\/doi.org\/10.14309\/ajg.0000000000001237","journal-title":"Am J Gastroenterol"},{"key":"2693_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.744505","volume":"8","author":"H Lin","year":"2022","unstructured":"Lin H, Bai Z, Meng F, Wu Y, Luo L, Shukla A et al (2022) Epidemiology and risk factors of portal venous system thrombosis in patients with inflammatory bowel disease: a systematic review and meta-analysis. Front Med 8:744505. https:\/\/doi.org\/10.3389\/fmed.2021.744505","journal-title":"Front Med"},{"key":"2693_CR14","doi-asserted-by":"publisher","first-page":"S349","DOI":"10.14309\/01.ajg.0001133960.41734.57","volume":"120","author":"R Aljohani","year":"2025","unstructured":"Aljohani R, Abualnaja A, Attamimi M, Almutairdi A, Alrajhi E, Nawaz A et al (2025) S1625 Sex Differences in Cardiovascular and Venous Thromboembolic Complications in Inflammatory Bowel Disease: A Large Multicenter Study. Am J Gastroenterol 120:S349\u2013S349. https:\/\/doi.org\/10.14309\/01.ajg.0001133960.41734.57","journal-title":"Am J Gastroenterol"},{"key":"2693_CR15","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1080\/00365521.2016.1185464","volume":"51","author":"A Alatri","year":"2016","unstructured":"Alatri A, Schoepfer A, Fournier N, Engelberger RP, Safroneeva E, Vavricka S et al (2016) Prevalence and risk factors for venous thromboembolic complications in the Swiss inflammatory bowel disease cohort. Scand J Gastroenterol 51:1200\u20135. https:\/\/doi.org\/10.1080\/00365521.2016.1185464","journal-title":"Scand J Gastroenterol"},{"key":"2693_CR16","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1136\/gut.2010.228585","volume":"60","author":"MD Kappelman","year":"2011","unstructured":"Kappelman MD, Horvath-Puho E, Sandler RS, Rubin DT, Ullman TA, Pedersen L et al (2011) Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study. Gut 60:937\u201343. https:\/\/doi.org\/10.1136\/gut.2010.228585","journal-title":"Gut"},{"key":"2693_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.hsr.2023.100084","volume":"7","author":"A Ray","year":"2023","unstructured":"Ray A, Ch. Maharana K, Meenakshi S, Singh S (2023) Endothelial dysfunction and its relation in different disorders: recent update. Health Sci Rev 7:100084. https:\/\/doi.org\/10.1016\/j.hsr.2023.100084","journal-title":"Health Sci Rev"},{"key":"2693_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph191811242","volume":"19","author":"S Mu\u0107ka","year":"2022","unstructured":"Mu\u0107ka S, Miodo\u0144ska M, Jakubiak GK, Starzak M, Cie\u015blar G, Stanek A (2022) Endothelial function assessment by flow-mediated dilation method: a valuable tool in the evaluation of the cardiovascular system. Int J Environ Res Public Health 19:11242. https:\/\/doi.org\/10.3390\/ijerph191811242","journal-title":"Int J Environ Res Public Health"},{"key":"2693_CR19","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1572-0241.2006.00943.x","volume":"102","author":"S Danese","year":"2007","unstructured":"Danese S, Papa A, Saibeni S, Repici A, Malesci A, Vecchi M (2007) Inflammation and coagulation in inflammatory bowel disease: the clot thickens. Am J Gastroenterol 102:174\u201386. https:\/\/doi.org\/10.1111\/j.1572-0241.2006.00943.x","journal-title":"Am J Gastroenterol"},{"key":"2693_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-026-04603-0","volume":"26","author":"H Wang","year":"2026","unstructured":"Wang H, Shao R, Wu S, Zhu Y, Zhang Z, Cui M et al (2026) The value of platelet-associated parameters as biomarkers in evaluating the disease activity of inflammatory bowel disease: a systematic review and meta-analysis. BMC Gastroenterol 26:104. https:\/\/doi.org\/10.1186\/s12876-026-04603-0","journal-title":"BMC Gastroenterol"},{"key":"2693_CR21","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.crohns.2012.05.016","volume":"7","author":"J Palkovits","year":"2013","unstructured":"Palkovits J, Novacek G, Kollars M, Hron G, Osterode W, Quehenberger P et al (2013) Tissue factor exposing microparticles in inflammatory bowel disease. J Crohns Colitis 7:222\u20139. https:\/\/doi.org\/10.1016\/j.crohns.2012.05.016","journal-title":"J Crohns Colitis"},{"key":"2693_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-5922.2010.00171.x","author":"M Cesari","year":"2010","unstructured":"Cesari M, Pahor M, Incalzi RA (2010) Review: plasminogen activator inhibitor\u20101 (PAI\u20101): a key factor linking fibrinolysis and age\u2010related subclinical and clinical conditions. Cardiovasc Ther. https:\/\/doi.org\/10.1111\/j.1755-5922.2010.00171.x","journal-title":"Cardiovasc Ther"},{"key":"2693_CR23","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1055\/a-1827-7464","volume":"06","author":"GE Eagle","year":"2022","unstructured":"Eagle GE, Schulman S (2022) High factor VIII levels and recurrent thromboembolism in patients with and without inflammatory bowel disease: a retrospective comparative study. TH Open 06:e147\u201353. https:\/\/doi.org\/10.1055\/a-1827-7464","journal-title":"TH Open"},{"key":"2693_CR24","doi-asserted-by":"publisher","first-page":"1680317","DOI":"10.3389\/fimmu.2025.1680317","volume":"16","author":"K Prz\u0119czek","year":"2025","unstructured":"Prz\u0119czek K, Cibor D, Zwoli\u0144ska-Wcis\u0142o M, Owczarek D (2025) Circulating cell adhesion molecules as biomarkers in inflammatory bowel disease: a systematic review and meta-analysis. Front Immunol 16:1680317. https:\/\/doi.org\/10.3389\/fimmu.2025.1680317","journal-title":"Front Immunol"},{"key":"2693_CR25","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/MCG.0000000000000618","volume":"51","author":"P Gu","year":"2017","unstructured":"Gu P, Theiss A, Han J, Feagins LA (2017) Increased cell adhesion molecules, PECAM-1, ICAM-3, or VCAM-1, predict increased risk for flare in patients with quiescent inflammatory bowel disease. J Clin Gastroenterol 51:522\u20137. https:\/\/doi.org\/10.1097\/MCG.0000000000000618","journal-title":"J Clin Gastroenterol"},{"key":"2693_CR26","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v18.i41.5848","volume":"18","author":"G M\u0171zes","year":"2012","unstructured":"M\u0171zes G (2012) Changes of the cytokine profile in inflammatory bowel diseases. World J Gastroenterol 18:5848. https:\/\/doi.org\/10.3748\/wjg.v18.i41.5848","journal-title":"World J Gastroenterol"},{"key":"2693_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11113179","volume":"11","author":"H Wu","year":"2022","unstructured":"Wu H, Xu M, Hao H, Hill MA, Xu C, Liu Z (2022) Endothelial dysfunction and arterial stiffness in patients with inflammatory bowel disease: a systematic review and meta-analysis. J Clin Med 11:3179. https:\/\/doi.org\/10.3390\/jcm11113179","journal-title":"J Clin Med"},{"key":"2693_CR28","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000355","author":"K Ozturk","year":"2015","unstructured":"Ozturk K, Guler AK, Cakir M, Ozen A, Demirci H, Turker T et al (2015) Pulse wave velocity, intima media thickness, and flow-mediated dilatation in patients with normotensive normoglycemic inflammatory bowel disease: Inflamm Bowel Dis. https:\/\/doi.org\/10.1097\/MIB.0000000000000355","journal-title":"Inflamm Bowel Dis"},{"key":"2693_CR29","doi-asserted-by":"publisher","first-page":"e427","DOI":"10.1016\/j.crohns.2013.02.001","volume":"7","author":"M Principi","year":"2013","unstructured":"Principi M, Mastrolonardo M, Scicchitano P, Gesualdo M, Sassara M, Guida P et al (2013) Endothelial function and cardiovascular risk in active inflammatory bowel diseases. J Crohns Colitis 7:e427\u201333. https:\/\/doi.org\/10.1016\/j.crohns.2013.02.001","journal-title":"J Crohns Colitis"},{"key":"2693_CR30","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1194\/jlr.P600014-JLR200","volume":"48","author":"RJ Bisoendial","year":"2007","unstructured":"Bisoendial RJ, Kastelein JJP, Peters SLM, Levels JHM, Birjmohun R, Rotmans JI et al (2007) Effects of CRP infusion on endothelial function and coagulation in normocholesterolemic and hypercholesterolemic subjects. J Lipid Res 48:952\u201360. https:\/\/doi.org\/10.1194\/jlr.P600014-JLR200","journal-title":"J Lipid Res"},{"key":"2693_CR31","doi-asserted-by":"publisher","first-page":"4866","DOI":"10.3748\/wjg.v26.i32.4866","volume":"26","author":"D Brnic","year":"2020","unstructured":"Brnic D, Martinovic D, Zivkovic PM, Tokic D, Vilovic M, Rusic D et al (2020) Inactive matrix Gla protein is elevated in patients with inflammatory bowel disease. World J Gastroenterol 26:4866\u201377. https:\/\/doi.org\/10.3748\/wjg.v26.i32.4866","journal-title":"World J Gastroenterol"},{"key":"2693_CR32","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.bcp.2019.05.030","volume":"166","author":"P Gresele","year":"2019","unstructured":"Gresele P, Momi S, Guglielmini G (2019) Nitric oxide-enhancing or -releasing agents as antithrombotic drugs. Biochem Pharmacol 166:300\u2013312. https:\/\/doi.org\/10.1016\/j.bcp.2019.05.030","journal-title":"Biochem Pharmacol"},{"key":"2693_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/membranes12010073","volume":"12","author":"P Winnersbach","year":"2022","unstructured":"Winnersbach P, Hosseinnejad A, Breuer T, Fechter T, Jakob F, Schwaneberg U et al (2022) Endogenous nitric oxide-releasing microgel coating prevents clot formation on oxygenator fibers exposed to in vitro blood flow. Membranes 12:73. https:\/\/doi.org\/10.3390\/membranes12010073","journal-title":"Membranes"},{"key":"2693_CR34","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1161\/hh0801.089861","volume":"88","author":"J Loscalzo","year":"2001","unstructured":"Loscalzo J (2001) Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circ Res 88:756\u201362. https:\/\/doi.org\/10.1161\/hh0801.089861","journal-title":"Circ Res"},{"key":"2693_CR35","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1046\/j.1538-7836.2003.00180.x","volume":"1","author":"JE Freedman","year":"2003","unstructured":"Freedman JE, Loscalzo J (2003) Nitric oxide and its relationship to thrombotic disorders. J Thromb Haemost 1:1183\u20131188. https:\/\/doi.org\/10.1046\/j.1538-7836.2003.00180.x","journal-title":"J Thromb Haemost"},{"key":"2693_CR36","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1161\/01.CIR.101.18.2144","volume":"101","author":"Y Yang","year":"2000","unstructured":"Yang Y, Loscalzo J (2000) Regulation of tissue factor expression in human microvascular endothelial cells by nitric oxide. Circulation 101:2144\u20138. https:\/\/doi.org\/10.1161\/01.CIR.101.18.2144","journal-title":"Circulation"},{"key":"2693_CR37","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/S0016-5085(03)00699-1","volume":"125","author":"OA Hatoum","year":"2003","unstructured":"Hatoum OA, Binion DG, Otterson MF, Gutterman DD (2003) Acquired microvascular dysfunction in inflammatory bowel disease: loss of nitric oxide-mediated vasodilation. Gastroenterology 125:58\u201369. https:\/\/doi.org\/10.1016\/S0016-5085(03)00699-1","journal-title":"Gastroenterology"},{"key":"2693_CR38","doi-asserted-by":"publisher","first-page":"5703","DOI":"10.1172\/JCI126923","volume":"130","author":"J Baier","year":"2020","unstructured":"Baier J, G\u00e4nsbauer M, Giessler C, Arnold H, Muske M, Schleicher U et al (2020) Arginase impedes the resolution of colitis by altering the microbiome and metabolome. J Clin Invest 130:5703\u201320. https:\/\/doi.org\/10.1172\/JCI126923","journal-title":"J Clin Invest"},{"key":"2693_CR39","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s001340050745","volume":"24","author":"M Gerlach","year":"1998","unstructured":"Gerlach M, Keh D, Bezold G, Spielmann S, K\u00fcrer I, Peter RU et al (1998) Nitric oxide inhibits tissue factor synthesis, expression and activity in human monocytes by prior formation of peroxynitrite. Intensive Care Med 24:1199\u2013208. https:\/\/doi.org\/10.1007\/s001340050745","journal-title":"Intensive Care Med"},{"key":"2693_CR40","doi-asserted-by":"publisher","first-page":"G1323","DOI":"10.1152\/ajpgi.00499.2006","volume":"292","author":"S Horowitz","year":"2007","unstructured":"Horowitz S, Binion DG, Nelson VM, Kanaa Y, Javadi P, Lazarova Z et al (2007) Increased arginase activity and endothelial dysfunction in human inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 292:G1323\u201336. https:\/\/doi.org\/10.1152\/ajpgi.00499.2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2693_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-017-2399-x","volume":"10","author":"C Zhu","year":"2017","unstructured":"Zhu C, Yu Y, Montani J-P, Ming X-F, Yang Z (2017) Arginase-I enhances vascular endothelial inflammation and senescence through eNOS-uncoupling. BMC Res Notes 10:82. https:\/\/doi.org\/10.1186\/s13104-017-2399-x","journal-title":"BMC Res Notes"},{"key":"2693_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mvr.2014.11.002","volume":"98","author":"L Wang","year":"2015","unstructured":"Wang L, Bhatta A, Toque HA, Rojas M, Yao L, Xu Z et al (2015) Arginase inhibition enhances angiogenesis in endothelial cells exposed to hypoxia. Microvasc Res 98:1\u20138. https:\/\/doi.org\/10.1016\/j.mvr.2014.11.002","journal-title":"Microvasc Res"},{"key":"2693_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00228","author":"R Lucas","year":"2013","unstructured":"Lucas R, Czikora I, Sridhar S, Zemskov EA, Oseghale A, Circo S et al (2013) Arginase 1: An Unexpected Mediator of Pulmonary Capillary Barrier Dysfunction in Models of Acute Lung Injury. Front Immunol [Internet]. https:\/\/doi.org\/10.3389\/fimmu.2013.00228. [cited 2026 Mar 1];4","journal-title":"Front Immunol [Internet]"},{"key":"2693_CR44","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.3390\/ijms21051641","volume":"21","author":"M Krzystek-Korpacka","year":"2020","unstructured":"Krzystek-Korpacka M, Fleszar G, Bednarz-Misa M, Lewandowski I, Szczuka \u0141, Kempi\u0144ski I (2020) Transcriptional and Metabolomic Analysis of L-Arginine\/Nitric Oxide Pathway in Inflammatory Bowel Disease and Its Association with Local Inflammatory and Angiogenic Response: Preliminary Findings. Int J Mol Sci 21:1641. https:\/\/doi.org\/10.3390\/ijms21051641","journal-title":"Int J Mol Sci"},{"key":"2693_CR45","doi-asserted-by":"publisher","first-page":"117487","DOI":"10.1016\/j.cca.2023.117487","volume":"548","author":"V Singh","year":"2023","unstructured":"Singh V, Kaur R, Kumari P, Pasricha C, Singh R (2023) ICAM-1 and VCAM-1: gatekeepers in various inflammatory and cardiovascular disorders. Clin Chim Acta 548:117487. https:\/\/doi.org\/10.1016\/j.cca.2023.117487","journal-title":"Clin Chim Acta"},{"key":"2693_CR46","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.clinbiochem.2013.05.070","volume":"46","author":"L Stoner","year":"2013","unstructured":"Stoner L, Lucero AA, Palmer BR, Jones LM, Young JM, Faulkner J (2013) Inflammatory biomarkers for predicting cardiovascular disease. Clin Biochem 46:1353\u20131371. https:\/\/doi.org\/10.1016\/j.clinbiochem.2013.05.070","journal-title":"Clin Biochem"},{"key":"2693_CR47","doi-asserted-by":"publisher","first-page":"11104","DOI":"10.1016\/S0021-9258(19)49881-5","volume":"267","author":"GR Larsen","year":"1992","unstructured":"Larsen GR, Sako D, Ahern TJ, Shaffer M, Erban J, Sajer SA et al (1992) P-selectin and E-selectin. Distinct but overlapping leukocyte ligand specificities. J Biol Chem 267:11104\u201311110. https:\/\/doi.org\/10.1016\/S0021-9258(19)49881-5","journal-title":"J Biol Chem"},{"key":"2693_CR48","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3389\/fimmu.2019.00085","volume":"10","author":"M Mussbacher","year":"2019","unstructured":"Mussbacher M, Salzmann M, Brostjan C, Hoesel B, Schoergenhofer C, Datler H et al (2019) Cell Type-Specific Roles of NF-\u03baB Linking Inflammation and Thrombosis. Front Immunol 10:85. https:\/\/doi.org\/10.3389\/fimmu.2019.00085","journal-title":"Front Immunol"},{"key":"2693_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12071520","volume":"12","author":"A Mestrovic","year":"2024","unstructured":"Mestrovic A, Perkovic N, Bozic D, Kumric M, Vilovic M, Bozic J (2024) Precision medicine in inflammatory bowel disease: a spotlight on emerging molecular biomarkers. Biomedicines (Basel) 12:1520. https:\/\/doi.org\/10.3390\/biomedicines12071520","journal-title":"Biomedicines (Basel)"},{"key":"2693_CR50","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.thromres.2016.11.007","volume":"149","author":"M Levi","year":"2017","unstructured":"Levi M, Van Der Poll T (2017) Coagulation and sepsis. Thromb Res 149:38\u201344. https:\/\/doi.org\/10.1016\/j.thromres.2016.11.007","journal-title":"Thromb Res"},{"key":"2693_CR51","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1161\/01.RES.0000252802.25497.b7","volume":"100","author":"P Von Hundelshausen","year":"2007","unstructured":"Von Hundelshausen P, Weber C (2007) Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res 100:27\u201340. https:\/\/doi.org\/10.1161\/01.RES.0000252802.25497.b7","journal-title":"Circ Res"},{"key":"2693_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26041708","volume":"26","author":"YJ Chee","year":"2025","unstructured":"Chee YJ, Dalan R, Cheung C (2025) The interplay between immunity, inflammation and endothelial dysfunction. Int J Mol Sci 26:1708. https:\/\/doi.org\/10.3390\/ijms26041708","journal-title":"Int J Mol Sci"},{"key":"2693_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.595526","volume":"11","author":"G Aguilar","year":"2020","unstructured":"Aguilar G, Koning T, Ehrenfeld P, S\u00e1nchez FA (2020) Role of NO and S-nitrosylation in the expression of endothelial adhesion proteins that regulate leukocyte and tumor cell adhesion. Front Physiol 11:595526. https:\/\/doi.org\/10.3389\/fphys.2020.595526","journal-title":"Front Physiol"},{"key":"2693_CR54","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1182\/blood-2024-208039","volume":"144","author":"R Adili","year":"2024","unstructured":"Adili R, Roads N, Lazaro H, Chen J, Chung DW, L\u00f3pez JA (2024) An important role for P-selectin in thrombotic microangiopathy. Blood 144:182\u2013182. https:\/\/doi.org\/10.1182\/blood-2024-208039","journal-title":"Blood"},{"key":"2693_CR55","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1182\/bloodadvances.2017013995","volume":"2","author":"T Kalagara","year":"2018","unstructured":"Kalagara T, Moutsis T, Yang Y, Pappelbaum KI, Farken A, Cladder-Micus L et al (2018) The endothelial glycocalyx anchors von Willebrand factor fibers to the vascular endothelium. Blood Adv 2:2347\u201357. https:\/\/doi.org\/10.1182\/bloodadvances.2017013995","journal-title":"Blood Adv"},{"key":"2693_CR56","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1111\/jth.15689","volume":"20","author":"M Purdy","year":"2022","unstructured":"Purdy M, Obi A, Myers D, Wakefield T (2022) P- and E\u2010 selectin in venous thrombosis and non\u2010venous pathologies. J Thromb Haemost 20:1056\u20131066. https:\/\/doi.org\/10.1111\/jth.15689","journal-title":"J Thromb Haemost"},{"key":"2693_CR57","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/j.1365-3083.2008.02029.x","volume":"67","author":"V Videm","year":"2008","unstructured":"Videm V, Albrigtsen M (2008) Soluble ICAM-1 and VCAM\u20101 as markers of endothelial activation. Scand J Immunol 67:523\u201331. https:\/\/doi.org\/10.1111\/j.1365-3083.2008.02029.x","journal-title":"Scand J Immunol"},{"key":"2693_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13051154","volume":"13","author":"Z Li","year":"2025","unstructured":"Li Z, Zeng L, Huang W, Zhang X, Zhang L, Xie Q (2025) Angiogenic factors and inflammatory bowel diseases. Biomedicines 13:1154. https:\/\/doi.org\/10.3390\/biomedicines13051154","journal-title":"Biomedicines"},{"key":"2693_CR59","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/nri2171","volume":"7","author":"JS Pober","year":"2007","unstructured":"Pober JS, Sessa WC (2007) Evolving functions of endothelial cells in inflammation. Nat Rev Immunol 7:803\u2013815. https:\/\/doi.org\/10.1038\/nri2171","journal-title":"Nat Rev Immunol"},{"key":"2693_CR60","doi-asserted-by":"publisher","DOI":"10.1055\/a-2513-4381","volume":"09","author":"AM Brown","year":"2025","unstructured":"Brown AM, Nock S, Musgrave K, Unsworth AJ (2025) Vascular endothelial growth factor (VEGF) as a biomarker for cancer-associated venous thrombosis: a meta-analysis. TH Open 09:a-2513-4381. https:\/\/doi.org\/10.1055\/a-2513-4381","journal-title":"TH Open"},{"key":"2693_CR61","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.1182\/blood.V93.11.3811","volume":"93","author":"D Mechtcheriakova","year":"1999","unstructured":"Mechtcheriakova D, Wlachos A, Holzm\u00fcller H, Binder BR, Hofer E (1999) Vascular endothelial cell growth factor\u2013induced tissue factor expression in endothelial cells is mediated by EGR-1. Blood 93:3811\u201323. https:\/\/doi.org\/10.1182\/blood.V93.11.3811","journal-title":"Blood"},{"key":"2693_CR62","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0014-5793(02)02232-9","volume":"512","author":"F Selheim","year":"2002","unstructured":"Selheim F, Holmsen H, Vassbotn FS (2002) Identification of functional VEGF receptors on human platelets. FEBS Lett 512:107\u201310. https:\/\/doi.org\/10.1016\/S0014-5793(02)02232-9","journal-title":"FEBS Lett"},{"key":"2693_CR63","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10456-018-9648-z","volume":"22","author":"J Darden","year":"2019","unstructured":"Darden J, Payne LB, Zhao H, Chappell JC (2019) Excess vascular endothelial growth factor-A disrupts pericyte recruitment during blood vessel formation. Angiogenesis 22:167\u2013183. https:\/\/doi.org\/10.1007\/s10456-018-9648-z","journal-title":"Angiogenesis"},{"key":"2693_CR64","doi-asserted-by":"publisher","first-page":"931","DOI":"10.3390\/ijms23020931","volume":"23","author":"SA Dabravolski","year":"2022","unstructured":"Dabravolski SA, Khotina VA, Omelchenko AV, Kalmykov VA, Orekhov AN (2022) The role of the VEGF family in atherosclerosis development and its potential as treatment targets. Int J Mol Sci 23:931. https:\/\/doi.org\/10.3390\/ijms23020931","journal-title":"Int J Mol Sci"},{"issue":"7","key":"2693_CR65","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00018-022-04348-5","volume":"79","author":"M Akbarian","year":"2022","unstructured":"Akbarian M, Bertassoni LE, Tayebi L (2022) Biological aspects in controlling angiogenesis: current progress. Cell Mol Life Sci 79:349. https:\/\/doi.org\/10.1007\/s00018-022-04348-5","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"2693_CR66","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12959-025-00770-4","volume":"23","author":"J Zhou","year":"2025","unstructured":"Zhou J, Wu M, Chen T, Niu P, Zhu Y, Liu Y et al (2025) Thromboembolic events associated with angiogenesis inhibitors: a real-world study of data from the food and drug administration adverse event reporting system (FAERS) database. Thromb J 23:83. https:\/\/doi.org\/10.1186\/s12959-025-00770-4","journal-title":"Thromb J"},{"key":"2693_CR67","doi-asserted-by":"publisher","DOI":"10.1111\/eci.14361","volume":"55","author":"S Zoroddu","year":"2025","unstructured":"Zoroddu S, Di Lorenzo B, Paliogiannis P, Mangoni AA, Carru C, Zinellu A (2025) Vascular endothelial growth factor in inflammatory bowel disease: a systematic review and meta-analysis. Eur J Clin Invest 55:e14361. https:\/\/doi.org\/10.1111\/eci.14361","journal-title":"Eur J Clin Invest"},{"key":"2693_CR68","doi-asserted-by":"publisher","first-page":"4311","DOI":"10.4049\/jimmunol.1501443","volume":"196","author":"K Bakirtzi","year":"2016","unstructured":"Bakirtzi K, Law IKM, Xue X, Iliopoulos D, Shah YM, Pothoulakis C (2016) Neurotensin promotes the development of colitis and intestinal angiogenesis via Hif-1\u03b1\u2013miR-210 signaling. J Immunol 196:4311\u201321. https:\/\/doi.org\/10.4049\/jimmunol.1501443","journal-title":"J Immunol"},{"key":"2693_CR69","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1053\/j.gastro.2008.09.064","volume":"136","author":"F Scaldaferri","year":"2009","unstructured":"Scaldaferri F, Vetrano S, Sans M, Arena V, Straface G, Stigliano E et al (2009) VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis. Gastroenterology 136:585\u2013595.e5. https:\/\/doi.org\/10.1053\/j.gastro.2008.09.064","journal-title":"Gastroenterology"},{"key":"2693_CR70","doi-asserted-by":"publisher","first-page":"936","DOI":"10.7150\/ijms.8277","volume":"11","author":"ND Zdravkovic","year":"2014","unstructured":"Zdravkovic ND, Jovanovic IP, Radosavljevic GD, Arsenijevic AN, Zdravkovic ND, Mitrovic SL et al (2014) Potential dual immunomodulatory role of VEGF in ulcerative colitis and colorectal carcinoma. Int J Med Sci 11:936\u201347. https:\/\/doi.org\/10.7150\/ijms.8277","journal-title":"Int J Med Sci"},{"key":"2693_CR71","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.immuni.2019.03.026","volume":"50","author":"S Kang","year":"2019","unstructured":"Kang S, Tanaka T, Narazaki M, Kishimoto T (2019) Targeting interleukin-6 signaling in clinic. Immunity 50:1007\u201323. https:\/\/doi.org\/10.1016\/j.immuni.2019.03.026","journal-title":"Immunity"},{"key":"2693_CR72","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/intimm\/dxu081","volume":"27","author":"S Kang","year":"2015","unstructured":"Kang S, Tanaka T, Kishimoto T (2015) Therapeutic uses of anti-interleukin-6 receptor antibody. Int Immunol 27:21\u201329. https:\/\/doi.org\/10.1093\/intimm\/dxu081","journal-title":"Int Immunol"},{"key":"2693_CR73","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/964131","volume":"2015","author":"S O\u2019Sullivan","year":"2015","unstructured":"O\u2019Sullivan S, Gilmer JF, Medina C (2015) Matrix metalloproteinases in inflammatory bowel disease: an update. Mediators Inflamm 2015:964131. https:\/\/doi.org\/10.1155\/2015\/964131","journal-title":"Mediators Inflamm"},{"key":"2693_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2009\/275072","volume":"2009","author":"Y-D Wang","year":"2009","unstructured":"Wang Y-D, Tan X-Y, Zhang K (2009) Correlation of plasma MMP-1 and TIMP-1 levels and the colonic mucosa expressions in patients with ulcerative colitis. Mediators Inflamm 2009:1\u20135. https:\/\/doi.org\/10.1155\/2009\/275072","journal-title":"Mediators Inflamm"},{"key":"2693_CR75","doi-asserted-by":"publisher","first-page":"G175","DOI":"10.1152\/ajpgi.90454.2008","volume":"296","author":"P Garg","year":"2009","unstructured":"Garg P, Vijay-Kumar M, Wang L, Gewirtz AT, Merlin D, Sitaraman SV (2009) Matrix metalloproteinase-9-mediated tissue injury overrides the protective effect of matrix metalloproteinase-2 during colitis. Am J Physiol-Gastrointest Liver Physiol 296:G175\u2013G184. https:\/\/doi.org\/10.1152\/ajpgi.90454.2008","journal-title":"Am J Physiol-Gastrointest Liver Physiol"},{"key":"2693_CR76","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/S0016-5085(99)70339-2","volume":"117","author":"MD Baugh","year":"1999","unstructured":"Baugh MD, Perry MJ, Hollander AP, Davies DR, Cross SS, Lobo AJ et al (1999) Matrix metalloproteinase levels are elevated in inflammatory bowel disease. Gastroenterology 117:814\u2013822. https:\/\/doi.org\/10.1016\/S0016-5085(99)70339-2","journal-title":"Gastroenterology"},{"key":"2693_CR77","doi-asserted-by":"publisher","DOI":"10.4178\/epih.e2024046","volume":"46","author":"D Han","year":"2024","unstructured":"Han D, Yu F, Zheng L (2024) Causal effect of serum matrix metalloproteinase levels on venous thromboembolism: a Mendelian randomization study. Epidemiol Health 46:e2024046. https:\/\/doi.org\/10.4178\/epih.e2024046","journal-title":"Epidemiol Health"},{"key":"2693_CR78","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1161\/01.CIR.0000058700.41738.12","volume":"107","author":"S Blankenberg","year":"2003","unstructured":"Blankenberg S, Rupprecht HJ, Poirier O, Bickel C, Smieja M, Hafner G et al (2003) Plasma Concentrations and Genetic Variation of Matrix Metalloproteinase 9 and Prognosis of Patients With Cardiovascular Disease. Circulation 107:1579\u20131585. https:\/\/doi.org\/10.1161\/01.CIR.0000058700.41738.12","journal-title":"Circulation"},{"key":"2693_CR79","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s11239-019-02004-7","volume":"49","author":"US Owolabi","year":"2020","unstructured":"Owolabi US, Amraotkar AR, Coulter AR, Singam NSV, Aladili BN, Singh A et al (2020) Change in matrix metalloproteinase 2, 3, and 9 levels at the time of and after acute atherothrombotic myocardial infarction. J Thromb Thrombolysis 49:235\u201344. https:\/\/doi.org\/10.1007\/s11239-019-02004-7","journal-title":"J Thromb Thrombolysis"},{"key":"2693_CR80","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M004218200","author":"AA Belaaouaj","year":"2000","unstructured":"Belaaouaj AA (2000) Matrix metalloproteinases cleave tissue factor pathway inhibitor: effects on coagulation. J Biol Chem. https:\/\/doi.org\/10.1074\/jbc.M004218200","journal-title":"J Biol Chem"},{"key":"2693_CR81","doi-asserted-by":"publisher","first-page":"392","DOI":"10.2741\/e386","volume":"E4","author":"RD Simari","year":"2012","unstructured":"Simari RD (2012) Tissue factor pathway inhibitor as a multifunctional mediator of vascular structure. Front Biosci E4:392\u2013400. https:\/\/doi.org\/10.2741\/e386","journal-title":"Front Biosci"},{"key":"2693_CR82","doi-asserted-by":"publisher","first-page":"113262","DOI":"10.1016\/j.isci.2025.113262","volume":"28","author":"C Jacquet","year":"2025","unstructured":"Jacquet C, Gustafsson R, Patel AK, Hansson M, Rankin G, Bano F et al (2025) Matrix metalloproteinase-9 mediates endothelial glycocalyx degradation and correlates with severity of hemorrhagic fever with renal syndrome. iScience 28:113262. https:\/\/doi.org\/10.1016\/j.isci.2025.113262","journal-title":"iScience"},{"key":"2693_CR83","doi-asserted-by":"publisher","first-page":"1251876","DOI":"10.3389\/fimmu.2023.1251876","volume":"14","author":"S Yung","year":"2023","unstructured":"Yung S, Chan TM (2023) Endothelial cell activation and glycocalyx shedding - potential as biomarkers in patients with lupus nephritis. Front Immunol 14:1251876. https:\/\/doi.org\/10.3389\/fimmu.2023.1251876","journal-title":"Front Immunol"},{"key":"2693_CR84","doi-asserted-by":"publisher","first-page":"4386","DOI":"10.3390\/jcm12134386","volume":"12","author":"H Matsumoto","year":"2023","unstructured":"Matsumoto H, Annen S, Mukai N, Ohshita M, Murata S, Harima Y et al (2023) Circulating Syndecan-1 Levels Are Associated with Chronological Coagulofibrinolytic Responses and the Development of Disseminated Intravascular Coagulation (DIC) after Trauma: A Retrospective Observational Study. J Clin Med 12:4386. https:\/\/doi.org\/10.3390\/jcm12134386","journal-title":"J Clin Med"},{"key":"2693_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.898592","volume":"9","author":"EK Patterson","year":"2022","unstructured":"Patterson EK, Cepinskas G, Fraser DD (2022) Endothelial glycocalyx degradation in critical illness and injury. Front Med 9:898592. https:\/\/doi.org\/10.3389\/fmed.2022.898592","journal-title":"Front Med"},{"key":"2693_CR86","doi-asserted-by":"publisher","DOI":"10.3390\/biom11040585","volume":"11","author":"AF Prado","year":"2021","unstructured":"Prado AF, Batista RIM, Tanus-Santos JE, Gerlach RF (2021) Matrix metalloproteinases and arterial hypertension: role of oxidative stress and nitric oxide in vascular functional and structural alterations. Biomolecules 11:585. https:\/\/doi.org\/10.3390\/biom11040585","journal-title":"Biomolecules"},{"key":"2693_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073868","volume":"23","author":"J Mandel","year":"2022","unstructured":"Mandel J, Casari M, Stepanyan M, Martyanov A, Deppermann C (2022) Beyond hemostasis: platelet innate immune interactions and thromboinflammation. Int J Mol Sci 23:3868. https:\/\/doi.org\/10.3390\/ijms23073868","journal-title":"Int J Mol Sci"},{"key":"2693_CR88","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ajpath.2013.03.014","volume":"183","author":"EY Senchenkova","year":"2013","unstructured":"Senchenkova EY, Komoto S, Russell J, Almeida-Paula LD, Yan L-S, Zhang S et al (2013) Interleukin-6 Mediates the Platelet Abnormalities and Thrombogenesis Associated with Experimental Colitis. Am J Pathol 183:173\u2013181. https:\/\/doi.org\/10.1016\/j.ajpath.2013.03.014","journal-title":"Am J Pathol"},{"key":"2693_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.tru.2022.100117","volume":"8","author":"L Ma","year":"2022","unstructured":"Ma L, Willey J (2022) The interplay between inflammation and thrombosis in COVID-19: mechanisms, therapeutic strategies, and challenges. Thromb Update 8:100117. https:\/\/doi.org\/10.1016\/j.tru.2022.100117","journal-title":"Thromb Update"},{"key":"2693_CR90","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1111\/jth.14574","volume":"17","author":"M Warny","year":"2019","unstructured":"Warny M, Helby J, Birgens HS, Bojesen SE, Nordestgaard BG (2019) Arterial and venous thrombosis by high platelet count and high hematocrit: 108 521 individuals from the Copenhagen General Population Study. J Thromb Haemost 17:1898\u20131911. https:\/\/doi.org\/10.1111\/jth.14574","journal-title":"J Thromb Haemost"},{"key":"2693_CR91","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1111\/j.1538-7836.2012.04846.x","volume":"10","author":"KM Ho","year":"2012","unstructured":"Ho KM, Yip CB, Duff O (2012) Reactive thrombocytosis and risk of subsequent venous thromboembolism: a cohort study. J Thromb Haemost 10:1768\u201374. https:\/\/doi.org\/10.1111\/j.1538-7836.2012.04846.x","journal-title":"J Thromb Haemost"},{"key":"2693_CR92","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3324\/haematol.2020.270496","volume":"106","author":"H Al-Samkari","year":"2021","unstructured":"Al-Samkari H, Kessler CM, Auerbach M (2021) Recognition of thrombotic risk of thrombocytosis in iron deficiency. Haematologica 106:661\u2013663. https:\/\/doi.org\/10.3324\/haematol.2020.270496","journal-title":"Haematologica"},{"key":"2693_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/536062","volume":"2011","author":"JS Bleeker","year":"2011","unstructured":"Bleeker JS, Hogan WJ (2011) Thrombocytosis: diagnostic evaluation, thrombotic risk stratification, and risk-based management strategies. Thrombosis 2011:1\u201316. https:\/\/doi.org\/10.1155\/2011\/536062","journal-title":"Thrombosis"},{"key":"2693_CR94","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4038\/tsljh.v16i1.20","volume":"16","author":"CHKA Fernando","year":"2024","unstructured":"Fernando CHKA, Williams SHA, Costa YJ, Moratuwagama D, Warnakulasuriya TD, De Silva AP et al (2024) A low mean platelet volume indicates active inflammatory bowel disease; a sensitive model in resource poor settings. Sri Lanka J Haematol 16:21\u201327. https:\/\/doi.org\/10.4038\/tsljh.v16i1.20","journal-title":"Sri Lanka J Haematol"},{"key":"2693_CR95","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2174\/138161211795049804","volume":"17","author":"A Yuri Gasparyan","year":"2011","unstructured":"Yuri Gasparyan A, Ayvazyan L, P. Mikhailidis D, D. Kitas G (2011) Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des 17:47\u201358. https:\/\/doi.org\/10.2174\/138161211795049804","journal-title":"Curr Pharm Des"},{"key":"2693_CR96","doi-asserted-by":"publisher","first-page":"107602962210788","DOI":"10.1177\/10760296221078837","volume":"28","author":"Z Wang","year":"2022","unstructured":"Wang Z, Chen X, Wu J, Zhou Q, Liu H, Wu Y et al (2022) Low Mean Platelet Volume is Associated with Deep Vein Thrombosis in Older Patients with Hip Fracture. Clin Appl Thromb 28:10760296221078837. https:\/\/doi.org\/10.1177\/10760296221078837","journal-title":"Clin Appl Thromb"},{"key":"2693_CR97","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.823549","volume":"9","author":"MA Hamad","year":"2022","unstructured":"Hamad MA, Krauel K, Schanze N, Gauchel N, Stachon P, Nuehrenberg T et al (2022) Platelet subtypes in inflammatory settings. Front Cardiovasc Med 9:823549. https:\/\/doi.org\/10.3389\/fcvm.2022.823549","journal-title":"Front Cardiovasc Med"},{"key":"2693_CR98","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006323","volume":"96","author":"L Ye","year":"2017","unstructured":"Ye L, Zhang Y-P, Yu N, Jia Y-X, Wan S-J, Wang F-Y (2017) Serum platelet factor 4 is a reliable activity parameter in adult patients with inflammatory bowel disease: a pilot study. Medicine (Baltimore) 96:e6323. https:\/\/doi.org\/10.1097\/MD.0000000000006323","journal-title":"Medicine (Baltimore)"},{"key":"2693_CR99","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1046\/j.1365-2362.2000.00616.x","volume":"30","author":"R Vrij","year":"2000","unstructured":"Vrij R, Van Wersch Stockbr\u00fcgger (2000) Platelet factor 4 and \u03b2-thromboglobulin in inflammatory bowel disease and giant cell arteritis. Eur J Clin Invest 30:188\u2013194. https:\/\/doi.org\/10.1046\/j.1365-2362.2000.00616.x","journal-title":"Eur J Clin Invest"},{"key":"2693_CR100","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1477-9560-11-7","volume":"11","author":"MM Prechel","year":"2013","unstructured":"Prechel MM, Walenga JM (2013) Emphasis on the Role of PF4 in the Incidence, Pathophysiology and Treatment of Heparin Induced Thrombocytopenia. Thromb J 11:7. https:\/\/doi.org\/10.1186\/1477-9560-11-7","journal-title":"Thromb J"},{"key":"2693_CR101","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1007\/s00018-010-0306-x","volume":"67","author":"H-D Flad","year":"2010","unstructured":"Flad H-D, Brandt E (2010) Platelet-derived chemokines: pathophysiology and therapeutic aspects. Cell Mol Life Sci 67:2363\u20132386. https:\/\/doi.org\/10.1007\/s00018-010-0306-x","journal-title":"Cell Mol Life Sci"},{"key":"2693_CR102","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.3389\/fimmu.2020.02149","volume":"11","author":"SC Silva-Cardoso","year":"2020","unstructured":"Silva-Cardoso SC, Tao W, Angiolilli C, Lopes AP, Bekker CPJ, Devaprasad A et al (2020) CXCL4 Links Inflammation and Fibrosis by Reprogramming Monocyte-Derived Dendritic Cells in vitro. Front Immunol 11:2149. https:\/\/doi.org\/10.3389\/fimmu.2020.02149","journal-title":"Front Immunol"},{"key":"2693_CR103","doi-asserted-by":"publisher","first-page":"107602962094330","DOI":"10.1177\/1076029620943300","volume":"27","author":"G Wegrzyn","year":"2021","unstructured":"Wegrzyn G, Walborn A, Rondina M, Fareed J, Hoppensteadt D (2021) Biomarkers of Platelet Activation and Their Prognostic Value in Patients With Sepsis-Associated Disseminated Intravascular Coagulopathy. Clin Appl Thromb 27:1076029620943300. https:\/\/doi.org\/10.1177\/1076029620943300","journal-title":"Clin Appl Thromb"},{"key":"2693_CR104","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/S0016-5085(03)00289-0","volume":"124","author":"S Danese","year":"2003","unstructured":"Danese S, De La Motte C, Sturm A, Vogel JD, West GA, Strong SA et al (2003) Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients. Gastroenterology 124:1249\u20131264. https:\/\/doi.org\/10.1016\/S0016-5085(03)00289-0","journal-title":"Gastroenterology"},{"key":"2693_CR105","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1136\/gut.52.10.1435","volume":"52","author":"S Danese","year":"2003","unstructured":"Danese S, Katz JA, Saibeni S, Papa A, Gasbarrini A, Vecchi M et al (2003) Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients. Gut 52:1435\u20131441. https:\/\/doi.org\/10.1136\/gut.52.10.1435","journal-title":"Gut"},{"key":"2693_CR106","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.2353\/ajpath.2008.070593","volume":"172","author":"L Deban","year":"2008","unstructured":"Deban L, Correale C, Vetrano S, Malesci A, Danese S (2008) Multiple Pathogenic Roles of Microvasculature in Inflammatory Bowel Disease: A Jack of All Trades. Am J Pathol 172:1457\u20131466. https:\/\/doi.org\/10.2353\/ajpath.2008.070593","journal-title":"Am J Pathol"},{"key":"2693_CR107","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3390\/biology11020224","volume":"11","author":"K Pluta","year":"2022","unstructured":"Pluta K, Por\u0119bska K, Urbanowicz T, G\u0105secka A, Olasi\u0144ska-Wi\u015bniewska A, Targo\u0144ski R et al (2022) Platelet\u2013Leucocyte Aggregates as Novel Biomarkers in Cardiovascular Diseases. Biology 11:224. https:\/\/doi.org\/10.3390\/biology11020224","journal-title":"Biology"},{"key":"2693_CR108","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1161\/hc3801.095588","volume":"104","author":"AD Michelson","year":"2001","unstructured":"Michelson AD, Barnard MR, Krueger LA, Valeri CR, Furman MI (2001) Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 104:1533\u20137. https:\/\/doi.org\/10.1161\/hc3801.095588","journal-title":"Circulation"},{"key":"2693_CR109","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.thromres.2011.10.010","volume":"129","author":"C Cerletti","year":"2012","unstructured":"Cerletti C, Tamburrelli C, Izzi B, Gianfagna F, De Gaetano G (2012) Platelet-leukocyte interactions in thrombosis. Thromb Res 129:263\u2013266. https:\/\/doi.org\/10.1016\/j.thromres.2011.10.010","journal-title":"Thromb Res"},{"key":"2693_CR110","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1080\/09537104.2018.1430358","volume":"29","author":"M Finsterbusch","year":"2018","unstructured":"Finsterbusch M, Schrottmaier WC, Kral-Pointner JB, Salzmann M, Assinger A (2018) Measuring and interpreting platelet-leukocyte aggregates. Platelets 29:677\u2013685. https:\/\/doi.org\/10.1080\/09537104.2018.1430358","journal-title":"Platelets"},{"key":"2693_CR111","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1182\/blood.V93.3.876","volume":"93","author":"V Evangelista","year":"1999","unstructured":"Evangelista V, Manarini S, Sideri R, Rotondo S, Martelli N, Piccoli A et al (1999) Platelet\/polymorphonuclear leukocyte interaction: P-selectin triggers protein-tyrosine phosphorylation-dependent CD11b\/CD18 adhesion: role of PSGL-1 as a signaling molecule. Blood 93:876\u201385","journal-title":"Blood"},{"key":"2693_CR112","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.amjms.2016.05.034","volume":"352","author":"F Ren","year":"2016","unstructured":"Ren F, Mu N, Zhang X, Tan J, Li L, Zhang C et al (2016) Increased platelet-leukocyte aggregates are associated with myocardial no-reflow in patients with ST elevation myocardial infarction. Am J Med Sci 352:261\u20136. https:\/\/doi.org\/10.1016\/j.amjms.2016.05.034","journal-title":"Am J Med Sci"},{"key":"2693_CR113","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1093\/cvr\/cvaf105","volume":"121","author":"J Han","year":"2025","unstructured":"Han J, Bloxham CJ, Kirmes K, Viggiani G, Unkelbach LP, Von Scheidt M et al (2025) Platelet\u2013leukocyte aggregates in cardiovascular disease: prognostic significance and therapeutic potential. Cardiovasc Res 121:1679\u201396. https:\/\/doi.org\/10.1093\/cvr\/cvaf105","journal-title":"Cardiovasc Res"},{"key":"2693_CR114","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jcma.2012.12.015","volume":"76","author":"Y Tekelio\u011flu","year":"2013","unstructured":"Tekelio\u011flu Y, Uzun H, G\u00fc\u00e7er H (2013) Circulating platelet\u2013leukocyte aggregates in patients with inflammatory bowel disease. J Chin Med Assoc 76:182\u2013185. https:\/\/doi.org\/10.1016\/j.jcma.2012.12.015","journal-title":"J Chin Med Assoc"},{"key":"2693_CR115","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/00054725-200407000-00007","volume":"10","author":"PM Irving","year":"2004","unstructured":"Irving PM, Macey MG, Shah U, Webb L, Langmead L, Rampton DS (2004) Formation of Platelet-leukocyte Aggregates in Inflammatory Bowel Disease. Inflamm Bowel Dis 10:361\u2013372. https:\/\/doi.org\/10.1097\/00054725-200407000-00007","journal-title":"Inflamm Bowel Dis"},{"key":"2693_CR116","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/jth.13898","volume":"16","author":"K South","year":"2018","unstructured":"South K, Lane DA (2018) ADAMTS-13 and von Willebrand factor: a dynamic duo. J Thromb Haemost 16:6\u201318. https:\/\/doi.org\/10.1111\/jth.13898","journal-title":"J Thromb Haemost"},{"key":"2693_CR117","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1182\/blood-2007-05-093021","volume":"111","author":"K Shim","year":"2008","unstructured":"Shim K, Anderson PJ, Tuley EA, Wiswall E, Evan Sadler J (2008) Platelet-VWF complexes are preferred substrates of ADAMTS13 under fluid shear stress. Blood 111:651\u2013657. https:\/\/doi.org\/10.1182\/blood-2007-05-093021","journal-title":"Blood"},{"key":"2693_CR118","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1055\/s-0037-1615401","volume":"80","author":"UM Vischer","year":"1998","unstructured":"Vischer UM, Emeis JJ, Bilo HJ, Stehouwer CD, Thomsen C, Rasmussen O et al (1998) Von Willebrand factor (vWf) as a plasma marker of endothelial activation in diabetes: improved reliability with parallel determination of the vWf propeptide (vWf:AgII). Thromb Haemost 80:1002\u20137","journal-title":"Thromb Haemost"},{"key":"2693_CR119","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1111\/j.1538-7836.2005.01360.x","volume":"3","author":"J-F Dong","year":"2005","unstructured":"Dong J-F (2005) Cleavage of ultra\u2010large von Willebrand factor by ADAMTS\u201013 under flow conditions. J Thromb Haemost 3:1710\u20131716. https:\/\/doi.org\/10.1111\/j.1538-7836.2005.01360.x","journal-title":"J Thromb Haemost"},{"key":"2693_CR120","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1111\/jth.13696","volume":"15","author":"C Kawecki","year":"2017","unstructured":"Kawecki C, Lenting PJ, Denis CV (2017) Von Willebrand factor and inflammation. J Thromb Haemost 15:1285\u201394. https:\/\/doi.org\/10.1111\/jth.13696","journal-title":"J Thromb Haemost"},{"key":"2693_CR121","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1182\/blood.V88.8.2951.bloodjournal8882951","volume":"88","author":"A Borchiellini","year":"1996","unstructured":"Borchiellini A, Fijnvandraat K, Ten Cate J, Pajkrt D, Van Deventer S, Pasterkamp G et al (1996) Quantitative analysis of von Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1- deamino-8-D-arginine vasopressin in humans. Blood 88:2951\u20138. https:\/\/doi.org\/10.1182\/blood.V88.8.2951.bloodjournal8882951","journal-title":"Blood"},{"key":"2693_CR122","unstructured":"Manon-Jensen T, Lasse L\u00f8cke L, Sun S, Mortensen JH, He Y, Krag A et al (2019) Initiation of the Wound Healing Cascade in Inflammatory Bowel Disease: Assessment of Von Willebrand Factor ADAMTS-13 Processing and Formation in Crohn\u2019s Disease. EC Gastroenterol Dig Syst 6.\u00a0https:\/\/ecronicon.net\/assets\/ecgds\/pdf\/ECGDS-06-00323.pdf#:~:text=%E2%80%9CInitiation%20of%20the%20Wound%20Healing%20Cascade%20in%20Inflammatory%20Bowel%20Disease:%20Assessment%20of%20Von"},{"key":"2693_CR123","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.5152\/tjg.2019.19346","volume":"30","author":"B Yuzbasioglu","year":"2020","unstructured":"Yuzbasioglu B, Ustaoglu M, Yuzbasioglu S et al (2020) Levels of TAFI, TFPI and ADAMTS-13 in inflammatory bowel disease. Turk J Gastroenterol 30:1025\u20139. https:\/\/doi.org\/10.5152\/tjg.2019.19346","journal-title":"Turk J Gastroenterol"},{"key":"2693_CR124","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1093\/ibd\/izae142","volume":"30","author":"J Lagrange","year":"2024","unstructured":"Lagrange J, Ahmed MU, Arnone D, Lacolley P, Regnault V, Peyrin-Biroulet L et al (2024) Implications of von Willebrand factor in inflammatory bowel diseases: beyond bleeding and thrombosis. Inflamm Bowel Dis 30:2500\u20138. https:\/\/doi.org\/10.1093\/ibd\/izae142","journal-title":"Inflamm Bowel Dis"},{"key":"2693_CR125","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000214859","volume":"121","author":"HB Feys","year":"2009","unstructured":"Feys HB, Deckmyn H, Vanhoorelbeke K (2009) ADAMTS13 in health and disease. Acta Haematol 121:183\u20135. https:\/\/doi.org\/10.1159\/000214859","journal-title":"Acta Haematol"},{"key":"2693_CR126","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1111\/j.1538-7836.2008.02989.x","volume":"6","author":"WJ Cao","year":"2008","unstructured":"Cao WJ, Niiya M, Zheng XW, Shang DZ, Zheng XL (2008) Inflammatory cytokines inhibit ADAMTS13 synthesis in hepatic stellate cells and endothelial cells. J Thromb Haemost 6:1233\u20131235. https:\/\/doi.org\/10.1111\/j.1538-7836.2008.02989.x","journal-title":"J Thromb Haemost"},{"key":"2693_CR127","doi-asserted-by":"publisher","first-page":"4796","DOI":"10.3748\/wjg.v23.i26.4796","volume":"23","author":"D Cibor","year":"2017","unstructured":"Cibor D, Owczarek D, Butenas S, Salapa K, Mach T, Undas A (2017) Levels and activities of von Willebrand factor and metalloproteinase with thrombospondin type-1 motif, number 13 in inflammatory bowel diseases. World J Gastroenterol 23:4796. https:\/\/doi.org\/10.3748\/wjg.v23.i26.4796","journal-title":"World J Gastroenterol"},{"key":"2693_CR128","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1182\/bloodadvances.2020003135","volume":"5","author":"MS Edvardsen","year":"2021","unstructured":"Edvardsen MS, Hindberg K, Hansen E-S, Morelli VM, Ueland T, Aukrust P et al (2021) Plasma levels of von Willebrand factor and future risk of incident venous thromboembolism. Blood Adv 5:224\u2013232. https:\/\/doi.org\/10.1182\/bloodadvances.2020003135","journal-title":"Blood Adv"},{"key":"2693_CR129","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.3390\/biomedicines13092284","volume":"13","author":"P Djuric","year":"2025","unstructured":"Djuric P, Mladenovic Z, Jovic Z, Vukotic S, Spasic M, Mijuskovic M et al (2025) The Association of Elevated Factor VIII and von Willebrand Factor (vWF) Levels with SYNTAX Score in Patients with Chronic Coronary Syndrome. Biomedicines 13:2284. https:\/\/doi.org\/10.3390\/biomedicines13092284","journal-title":"Biomedicines"},{"key":"2693_CR130","doi-asserted-by":"publisher","DOI":"10.3390\/cimb47020108","volume":"47","author":"EA Starikova","year":"2025","unstructured":"Starikova EA, Mammedova JT, Rubinstein AA, Sokolov AV, Kudryavtsev IV (2025) Activation of the coagulation cascade as a universal danger sign. Curr Issues Mol Biol 47:108. https:\/\/doi.org\/10.3390\/cimb47020108","journal-title":"Curr Issues Mol Biol"},{"key":"2693_CR131","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.bcmd.2005.12.008","volume":"36","author":"N Mackman","year":"2006","unstructured":"Mackman N (2006) Role of tissue factor in hemostasis and thrombosis. Blood Cells Mol Dis 36:104\u2013107. https:\/\/doi.org\/10.1016\/j.bcmd.2005.12.008","journal-title":"Blood Cells Mol Dis"},{"key":"2693_CR132","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1213\/ane.0b013e31819bceb1","volume":"108","author":"N Mackman","year":"2009","unstructured":"Mackman N (2009) The role of tissue factor and factor VIIa in hemostasis. Anesth Analg 108:1447\u201352. https:\/\/doi.org\/10.1213\/ane.0b013e31819bceb1","journal-title":"Anesth Analg"},{"key":"2693_CR133","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1038\/s41467-025-57001-7","volume":"16","author":"G Leon","year":"2025","unstructured":"Leon G, Klavina PA, Rehill AM, Cooper SEJ, Dominik A, Basavarajappa SC et al (2025) Tissue factor-dependent colitogenic CD4\u2009+\u2009T cell thrombogenicity is regulated by activated protein C signalling. Nat Commun 16:1677. https:\/\/doi.org\/10.1038\/s41467-025-57001-7","journal-title":"Nat Commun"},{"key":"2693_CR134","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/MBC.0b013e328335d025","volume":"21","author":"B Cakal","year":"2010","unstructured":"Cakal B, Gokmen A, Yalinkilic M, Cakal E, Ayaz S, Nadir I et al (2010) Natural anticoagulant protein levels in Turkish patients with inflammatory bowel disease. Blood Coagul Fibrinolysis 21:118\u2013121. https:\/\/doi.org\/10.1097\/MBC.0b013e328335d025","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2693_CR135","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1023\/A:1018891323205","volume":"42","author":"A Stadnicki","year":"1997","unstructured":"Stadnicki A, Gonciarz M, Niewiarowski TJ, Hartleb J, Rudnicki M, Merrell NB et al (1997) Coagulation Systems and Neutrophils in the Activation of Plasma Contact and Active Phase of Ulcerative Colitis. Dig Dis Sci 42:2356\u20132366. https:\/\/doi.org\/10.1023\/A:1018891323205","journal-title":"Dig Dis Sci"},{"key":"2693_CR136","doi-asserted-by":"publisher","DOI":"10.20452\/pamw.4481","author":"D Cibor","year":"2019","unstructured":"Cibor D, Szczeklik K, Mach T, Owczarek D (2019) Tissue factor pathway inhibitor levels in patients with inflammatory bowel disease. Pol Arch Intern Med [Internet]. https:\/\/doi.org\/10.20452\/pamw.4481. [cited 2026 Mar 1]","journal-title":"Pol Arch Intern Med [Internet]"},{"key":"2693_CR137","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1136\/jcp.46.8.703","volume":"46","author":"L More","year":"1993","unstructured":"More L, Sim R, Hudson M, Dhillon AP, Pounder R, Wakefield AJ (1993) Immunohistochemical study of tissue factor expression in normal intestine and idiopathic inflammatory bowel disease. J Clin Pathol 46:703\u2013708. https:\/\/doi.org\/10.1136\/jcp.46.8.703","journal-title":"J Clin Pathol"},{"key":"2693_CR138","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.283581","author":"C Englisch","year":"2023","unstructured":"Englisch C, Moik F, Thaler J, Koder S, Mackman N, Preusser M et al (2023) Tissue factor pathway inhibitor is associated with risk of venous thromboembolism and all-cause mortality in patients with cancer. Haematologica. https:\/\/doi.org\/10.3324\/haematol.2023.283581","journal-title":"Haematologica"},{"key":"2693_CR139","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1002\/ibd.21206","volume":"16","author":"A Undas","year":"2010","unstructured":"Undas A, Owczarek D, Gissel M, Salapa K, Mann KG, Butenas S (2010) Activated factor XI and tissue factor in inflammatory bowel disease. Inflamm Bowel Dis 16:1447\u20131448. https:\/\/doi.org\/10.1002\/ibd.21206","journal-title":"Inflamm Bowel Dis"},{"key":"2693_CR140","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i1.53","volume":"20","author":"D Owczarek","year":"2014","unstructured":"Owczarek D (2014) Inflammatory bowel disease: epidemiology, pathology and risk factors for hypercoagulability. World J Gastroenterol 20:53. https:\/\/doi.org\/10.3748\/wjg.v20.i1.53","journal-title":"World J Gastroenterol"},{"key":"2693_CR141","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12959-015-0044-2","volume":"13","author":"M Giannotta","year":"2015","unstructured":"Giannotta M, Tapete G, Emmi G, Silvestri E, Milla M (2015) Thrombosis in inflammatory bowel diseases: what\u2019s the link? Thromb J 13:14. https:\/\/doi.org\/10.1186\/s12959-015-0044-2","journal-title":"Thromb J"},{"key":"2693_CR142","doi-asserted-by":"publisher","first-page":"8176","DOI":"10.1038\/s41467-025-62789-5","volume":"16","author":"AK Haj","year":"2025","unstructured":"Haj AK, Paul DS, Jurgens SJ, Eswaran H, Weng L-C, Ryu J et al (2025) Coagulation factor XII haploinsufficiency is protective against venous thromboembolism in a population-scale multidimensional analysis. Nat Commun 16:8176. https:\/\/doi.org\/10.1038\/s41467-025-62789-5","journal-title":"Nat Commun"},{"key":"2693_CR143","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.thromres.2009.11.028","volume":"125","author":"E Stavrou","year":"2010","unstructured":"Stavrou E, Schmaier AH (2010) Factor XII: what does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis. Thromb Res 125:210\u20135. https:\/\/doi.org\/10.1016\/j.thromres.2009.11.028","journal-title":"Thromb Res"},{"key":"2693_CR144","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1084\/jem.20052458","volume":"203","author":"C Kleinschnitz","year":"2006","unstructured":"Kleinschnitz C, Stoll G, Bendszus M, Schuh K, Pauer H-U, Burfeind P et al (2006) Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis. J Exp Med 203:513\u2013518. https:\/\/doi.org\/10.1084\/jem.20052458","journal-title":"J Exp Med"},{"key":"2693_CR145","doi-asserted-by":"publisher","first-page":"R206","DOI":"10.1186\/ar4399","volume":"15","author":"J B\u00e4ck","year":"2013","unstructured":"B\u00e4ck J, Lood C, Bengtsson AA, Ekdahl KN, Nilsson B (2013) Contact activation products are new potential biomarkers to evaluate the risk of thrombotic events in systemic lupus erythematosus. Arthritis Res Ther 15:R206. https:\/\/doi.org\/10.1186\/ar4399","journal-title":"Arthritis Res Ther"},{"key":"2693_CR146","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1111\/jth.15793","volume":"20","author":"KC Childers","year":"2022","unstructured":"Childers KC, Peters SC, Spiegel PC (2022) Structural insights into blood coagulation factor VIII: procoagulant complexes, membrane binding, and antibody inhibition. J Thromb Haemost 20:1957\u201370. https:\/\/doi.org\/10.1111\/jth.15793","journal-title":"J Thromb Haemost"},{"key":"2693_CR147","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s44313-024-00040-8","volume":"59","author":"S Park","year":"2024","unstructured":"Park S, Park JK (2024) Back to basics: the coagulation pathway. Blood Res 59:35. https:\/\/doi.org\/10.1007\/s44313-024-00040-8","journal-title":"Blood Res"},{"key":"2693_CR148","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1620\/tjem.132.93","volume":"132","author":"K Mori","year":"1980","unstructured":"Mori K, Watanabe H, Hiwatashi N, Sugai K, Goto Y (1980) Studies on blood coagulation in ulcerative colitis and Crohn\u2019s disease. Tohoku J Exp Med 132:93\u2013101. https:\/\/doi.org\/10.1620\/tjem.132.93","journal-title":"Tohoku J Exp Med"},{"key":"2693_CR149","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.2169\/internalmedicine.46.0237","volume":"46","author":"K Kume","year":"2007","unstructured":"Kume K, Yamasaki M, Tashiro M, Yoshikawa I, Otsuki M (2007) Activations of coagulation and fibrinolysis secondary to bowel inflammation in patients with ulcerative colitis. Intern Med 46:1323\u201330. https:\/\/doi.org\/10.2169\/internalmedicine.46.0237","journal-title":"Intern Med"},{"key":"2693_CR150","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/BF01072463","volume":"23","author":"AM Lake","year":"1978","unstructured":"Lake AM, Stauffer JQ, Stuart MJ (1978) Hemostatic alterations in inflammatory bowel disease: response to therapy. Am J Dig Dis 23:897\u2013902. https:\/\/doi.org\/10.1007\/BF01072463","journal-title":"Am J Dig Dis"},{"key":"2693_CR151","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1111\/jth.14741","volume":"18","author":"LM Raffield","year":"2020","unstructured":"Raffield LM, Lu AT, Szeto MD, Little A, Grinde KE, Shaw J et al (2020) Coagulation factor VIII: relationship to cardiovascular disease risk and whole genome sequence and epigenome-wide analysis in African Americans. J Thromb Haemost 18:1335\u201347. https:\/\/doi.org\/10.1111\/jth.14741","journal-title":"J Thromb Haemost"},{"key":"2693_CR152","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1056\/NEJM200008173430702","volume":"343","author":"PA Kyrle","year":"2000","unstructured":"Kyrle PA, Minar E, Hirschl M, Bialonczyk C, Stain M, Schneider B et al (2000) High Plasma Levels of Factor VIII and the Risk of Recurrent Venous Thromboembolism. N Engl J Med 343:457\u2013462. https:\/\/doi.org\/10.1056\/NEJM200008173430702","journal-title":"N Engl J Med"},{"key":"2693_CR153","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.thromres.2007.12.024","volume":"122","author":"B Cosmi","year":"2008","unstructured":"Cosmi B, Legnani C, Cini M, Favaretto E, Palareti G (2008) D-dimer and factor VIII are independent risk factors for recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis. Thromb Res 122:610\u2013617. https:\/\/doi.org\/10.1016\/j.thromres.2007.12.024","journal-title":"Thromb Res"},{"key":"2693_CR154","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1111\/j.1538-7836.2006.01935.x","volume":"4","author":"S Shrivastava","year":"2006","unstructured":"Shrivastava S, Ridker PM, Glynn RJ, Goldhaber SZ, Moll S, Bounameaux H et al (2006) D-dimer, factor VIII coagulant activity, low\u2010intensity warfarin and the risk of recurrent venous thromboembolism. J Thromb Haemost 4:1208\u201314. https:\/\/doi.org\/10.1111\/j.1538-7836.2006.01935.x","journal-title":"J Thromb Haemost"},{"key":"2693_CR155","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1161\/01.ATV.21.5.731","volume":"21","author":"PW Kamphuisen","year":"2001","unstructured":"Kamphuisen PW, Eikenboom JCJ, Bertina RM (2001) Elevated factor VIII levels and the risk of thrombosis. Arterioscler Thromb Vasc Biol 21:731\u20138. https:\/\/doi.org\/10.1161\/01.ATV.21.5.731","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2693_CR156","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2147\/PGPM.S383221","volume":"16","author":"LL Swystun","year":"2023","unstructured":"Swystun LL, Lillicrap D (2023) Current understanding of inherited modifiers of FVIII pharmacokinetic variation. Pharmacogenomics Pers Med 16:239\u201352. https:\/\/doi.org\/10.2147\/PGPM.S383221","journal-title":"Pharmacogenomics Pers Med"},{"key":"2693_CR157","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.jhep.2017.07.002","volume":"67","author":"R Carnevale","year":"2017","unstructured":"Carnevale R, Raparelli V, Nocella C, Bartimoccia S, Novo M, Severino A et al (2017) Gut-derived endotoxin stimulates factor VIII secretion from endothelial cells. Implications for hypercoagulability in cirrhosis. J Hepatol 67:950\u20136. https:\/\/doi.org\/10.1016\/j.jhep.2017.07.002","journal-title":"J Hepatol"},{"key":"2693_CR158","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.thromres.2009.10.012","volume":"125","author":"S Saibeni","year":"2010","unstructured":"Saibeni S, Saladino V, Chantarangkul V, Villa F, Bruno S, Vecchi M et al (2010) Increased thrombin generation in inflammatory bowel diseases. Thromb Res 125:278\u201382. https:\/\/doi.org\/10.1016\/j.thromres.2009.10.012","journal-title":"Thromb Res"},{"key":"2693_CR159","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1093\/ecco-jcc\/jjaa229","volume":"15","author":"J-P Motta","year":"2021","unstructured":"Motta J-P, Palese S, Giorgio C, Chapman K, Denadai-Souza A, Rousset P et al (2021) Increased mucosal thrombin is associated with Crohn\u2019s disease and causes inflammatory damage through protease-activated receptors activation. J Crohns Colitis 15:787\u201399. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaa229","journal-title":"J Crohns Colitis"},{"key":"2693_CR160","first-page":"459","volume":"22","author":"E Wypasek","year":"2013","unstructured":"Wypasek E, Undas A (2013) Protein C and protein S deficiency - practical diagnostic issues. Adv Clin Exp Med Off Organ Wroclaw Med Univ 22:459\u2013467","journal-title":"Adv Clin Exp Med Off Organ Wroclaw Med Univ"},{"key":"2693_CR161","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/978-1-62703-339-8_29","volume-title":"Haemostasis","author":"M Hepner","year":"2013","unstructured":"Hepner M, Karlaftis V (2013) Protein C. In: Monagle P (ed) Haemostasis. Humana Press, Totowa, NJ, pp 365\u201372. https:\/\/doi.org\/10.1007\/978-1-62703-339-8_29"},{"key":"2693_CR162","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1365-2257.2006.00746.x","volume":"28","author":"MJ Kovacs","year":"2006","unstructured":"Kovacs MJ, Kovacs J, Anderson J, Rodger MA, Mackinnon K, Wells PS (2006) Protein C and protein S levels can be accurately determined within 24 hours of diagnosis of acute venous thromboembolism. Clin Lab Haematol 28:9\u201313. https:\/\/doi.org\/10.1111\/j.1365-2257.2006.00746.x","journal-title":"Clin Lab Haematol"},{"key":"2693_CR163","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1111\/jth.15052","volume":"18","author":"AR Rezaie","year":"2020","unstructured":"Rezaie AR, Giri H (2020) Anticoagulant and signaling functions of antithrombin. J Thromb Haemost 18:3142\u20133153. https:\/\/doi.org\/10.1111\/jth.15052","journal-title":"J Thromb Haemost"},{"key":"2693_CR164","doi-asserted-by":"publisher","first-page":"4283","DOI":"10.3390\/ijms22084283","volume":"22","author":"C Schl\u00f6mmer","year":"2021","unstructured":"Schl\u00f6mmer C, Brandtner A, Bachler M (2021) Antithrombin and its role in host defense and inflammation. Int J Mol Sci 22:4283. https:\/\/doi.org\/10.3390\/ijms22084283","journal-title":"Int J Mol Sci"},{"key":"2693_CR165","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1097\/MEG.0b013e3282faa759","volume":"20","author":"IE Koutroubakis","year":"2008","unstructured":"Koutroubakis IE, Sfiridaki A, Tsiolakidou G, Coucoutsi C, Theodoropoulou A, Kouroumalis EA (2008) Plasma thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 levels in inflammatory bowel disease. Eur J Gastroenterol Hepatol 20:912\u2013916. https:\/\/doi.org\/10.1097\/MEG.0b013e3282faa759","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2693_CR166","doi-asserted-by":"publisher","first-page":"209","DOI":"10.20452\/pamw.1261","volume":"122","author":"D Owczarek","year":"2012","unstructured":"Owczarek D, Cibor D, Sa\u0142apa K, Cie\u015bla A, G\u0142owacki MK, Pocztar H et al (2012) Anti\u2013inflammatory and anticoagulant properties of the protein C system in inflammatory bowel disease. Pol Arch Intern Med 122:209\u2013216. https:\/\/doi.org\/10.20452\/pamw.1261","journal-title":"Pol Arch Intern Med"},{"key":"2693_CR167","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1182\/blood-2014-05-578328","volume":"124","author":"LV Mohan Rao","year":"2014","unstructured":"Mohan Rao LV, Esmon CT, Pendurthi UR (2014) Endothelial cell protein C receptor: a multiliganded and multifunctional receptor. Blood 124:1553\u20131562. https:\/\/doi.org\/10.1182\/blood-2014-05-578328","journal-title":"Blood"},{"key":"2693_CR168","doi-asserted-by":"publisher","first-page":"S266","DOI":"10.1097\/01.CCM.0000128032.85396.83","volume":"32","author":"EM Faioni","year":"2004","unstructured":"Faioni EM, Ferrero S, Fontana G, Gianelli U, Ciulla MM, Vecchi M et al (2004) Expression of endothelial protein C receptor and thrombomodulin in the intestinal tissue of patients with inflammatory bowel disease. Crit Care Med 32:S266\u2013S270. https:\/\/doi.org\/10.1097\/01.CCM.0000128032.85396.83","journal-title":"Crit Care Med"},{"key":"2693_CR169","doi-asserted-by":"publisher","first-page":"5055","DOI":"10.1182\/bloodadvances.2023010083","volume":"7","author":"D Gupta","year":"2023","unstructured":"Gupta D, Elwakiel A, Ranjan S, Pandey MK, Krishnan S, Ambreen S et al (2023) Activated protein C modulates T-cell metabolism and epigenetic FOXP3 induction via \u03b1-ketoglutarate. Blood Adv 7:5055\u20135068. https:\/\/doi.org\/10.1182\/bloodadvances.2023010083","journal-title":"Blood Adv"},{"key":"2693_CR170","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1084\/jem.20151118","volume":"213","author":"Y Kishi","year":"2016","unstructured":"Kishi Y, Kondo T, Xiao S, Yosef N, Gaublomme J, Wu C et al (2016) Protein C receptor (PROCR) is a negative regulator of Th17 pathogenicity. J Exp Med 213:2489\u2013501. https:\/\/doi.org\/10.1084\/jem.20151118","journal-title":"J Exp Med"},{"key":"2693_CR171","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1111\/jgh.15656","volume":"36","author":"A Gaowa","year":"2021","unstructured":"Gaowa A, Park EJ, Kawamoto E, Qin Y, Shimaoka M (2021) Recombinant soluble thrombomodulin accelerates epithelial stem cell proliferation in mouse intestinal organoids and promotes the mucosal healing in colitis. J Gastroenterol Hepatol 36:3149\u20133157. https:\/\/doi.org\/10.1111\/jgh.15656","journal-title":"J Gastroenterol Hepatol"},{"key":"2693_CR172","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s43556-025-00395-z","volume":"7","author":"X Yang","year":"2026","unstructured":"Yang X, Guo H, Zou M (2026) Inflammatory bowel diseases: pathological mechanisms and therapeutic perspectives. Mol Biomed 7:2. https:\/\/doi.org\/10.1186\/s43556-025-00395-z","journal-title":"Mol Biomed"},{"key":"2693_CR173","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/j.2042-7158.2012.01457.x","volume":"64","author":"M Flemmig","year":"2012","unstructured":"Flemmig M, Melzig MF (2012) Serine-proteases as plasminogen activators in terms of fibrinolysis. J Pharm Pharmacol 64:1025\u201339. https:\/\/doi.org\/10.1111\/j.2042-7158.2012.01457.x","journal-title":"J Pharm Pharmacol"},{"key":"2693_CR174","doi-asserted-by":"publisher","DOI":"10.4103\/0975-7406.76489","volume":"3","author":"S Jain","year":"2011","unstructured":"Jain S, Gautam V, Naseem S (2011) Acute-phase proteins: as diagnostic tool. J Pharm Bioallied Sci 3:118. https:\/\/doi.org\/10.4103\/0975-7406.76489","journal-title":"J Pharm Bioallied Sci"},{"key":"2693_CR175","doi-asserted-by":"publisher","first-page":"5821","DOI":"10.1111\/j.1742-4658.2005.04979.x","volume":"272","author":"M Swiatkowska","year":"2005","unstructured":"Swiatkowska M, Szemraj J, Cierniewski CS (2005) Induction of PAI-1 expression by tumor necrosis factor \u03b1 in endothelial cells is mediated by its responsive element located in the 4G\/5G site. FEBS J 272:5821\u20135831. https:\/\/doi.org\/10.1111\/j.1742-4658.2005.04979.x","journal-title":"FEBS J"},{"key":"2693_CR176","doi-asserted-by":"publisher","first-page":"22351","DOI":"10.1073\/pnas.2010229117","volume":"117","author":"S Kang","year":"2020","unstructured":"Kang S, Tanaka T, Inoue H, Ono C, Hashimoto S, Kioi Y et al (2020) IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome. Proc Natl Acad Sci 117:22351\u201322356. https:\/\/doi.org\/10.1073\/pnas.2010229117","journal-title":"Proc Natl Acad Sci"},{"key":"2693_CR177","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1111\/j.1538-7836.2006.01970.x","volume":"4","author":"S Saibeni","year":"2006","unstructured":"Saibeni S, Ciscato C, Vecchi M, Boscolo Anzoletti M, Kaczmarek E, Caccia S et al (2006) Antibodies to tissue-type plasminogen activator (t\u2010PA) in patients with inflammatory bowel disease: high prevalence, interactions with functional domains of t\u2010PA and possible implications in thrombosis. J Thromb Haemost 4:1510\u20131516. https:\/\/doi.org\/10.1111\/j.1538-7836.2006.01970.x","journal-title":"J Thromb Haemost"},{"key":"2693_CR178","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.7150\/ijbs.75890","volume":"19","author":"X Wang","year":"2023","unstructured":"Wang X, Guo L, Huang J, Jiang S, Li N, Mu H-H et al (2023) Plasminogen Activator Inhibitor-1 Potentiates Neutrophil Infiltration and Tissue Injury in Colitis. Int J Biol Sci 19:2132\u20132149. https:\/\/doi.org\/10.7150\/ijbs.75890","journal-title":"Int J Biol Sci"},{"key":"2693_CR179","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13081864","volume":"13","author":"R \u0160anti\u0107","year":"2025","unstructured":"\u0160anti\u0107 R, Pavlovi\u0107 N, Kumri\u0107 M, Vilovi\u0107 M, Bo\u017ei\u0107 J (2025) Pathophysiological links between inflammatory bowel disease and cardiovascular disease: the role of dysbiosis and emerging biomarkers. Biomedicines 13:1864. https:\/\/doi.org\/10.3390\/biomedicines13081864","journal-title":"Biomedicines"},{"key":"2693_CR180","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1007\/BF02208650","volume":"40","author":"JC Souto","year":"1995","unstructured":"Souto JC, Mart\u00ednez E, Roca M, Mateo J, Pujol J, Gonz\u00e1lez D et al (1995) Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease. Dig Dis Sci 40:1883\u20139. https:\/\/doi.org\/10.1007\/BF02208650","journal-title":"Dig Dis Sci"},{"key":"2693_CR181","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1136\/gut.30.2.188","volume":"30","author":"E De Jong","year":"1989","unstructured":"De Jong E, Porte RJ, Knot EA, Verheijen JH, Dees J (1989) Disturbed fibrinolysis in patients with inflammatory bowel disease. A study in blood plasma, colon mucosa, and faeces. Gut 30:188\u2013194. https:\/\/doi.org\/10.1136\/gut.30.2.188","journal-title":"Gut"},{"key":"2693_CR182","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1111\/j.1572-0241.2004.40923.x","volume":"99","author":"R Quera","year":"2004","unstructured":"Quera R, Shanahan F (2004) Thromboembolism-an important manifestation of inflammatory bowel disease. Am J Gastroenterol 99:1971\u20133. https:\/\/doi.org\/10.1111\/j.1572-0241.2004.40923.x","journal-title":"Am J Gastroenterol"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-026-02693-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-026-02693-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-026-02693-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T02:18:31Z","timestamp":1781576311000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-026-02693-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":182,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["2693"],"URL":"https:\/\/doi.org\/10.1007\/s00109-026-02693-7","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"17 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not appliacble.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"86"}}